Fidia Pharma Group

Fidia Farmaceutici is a leading Italian multinational pharmaceutical company founded in 1946, specializing in the research, development, and manufacturing of hyaluronic acid-based products. The company is globally recognized for its expertise in hyaluronan science, maintaining a fully integrated manufacturing process from raw material production via fermentation to finished dosage forms. Its extensive portfolio spans several therapeutic areas, including joint care, wound healing, ophthalmology, aesthetics, and neuroscience. With a strong international presence through numerous subsidiaries, Fidia provides a diverse range of prescription drugs, medical devices, and food supplements to healthcare professionals and patients in over 100 countries. The group continues to expand its global footprint through strategic acquisitions, such as the anti-inflammatory portfolio from Sanofi.